Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.2.1.51 extracted from

  • Moreno-Clavijo, E.; Carmona, A.T.; Vera-Ayoso, Y.; Moreno-Vargas, A.J.; Bello, C.; Vogel, P.; Robina, I.
    Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases (2009), Org. Biomol. Chem., 7, 1192-1202.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
(2S,3R,4S,5S)-2-methyl-5-(phenylamino)pyrrolidine-3,4-diol inhibitor shares the same absolute configuration as C(2,3,4,5) of alpha-L-fucopyranosides Bos taurus
(2S,3S,4R,5S)-2-(1H-benzimidazol-2-yl)-5-methylpyrrolidine-3,4-diol inhibitor shares the same absolute configuration as C(2,3,4,5) of alpha-L-fucopyranosides Bos taurus
(2S,3S,4R,5S)-2-[(biphenyl-4-ylamino)methyl]-5-methylpyrrolidine-3,4-diol inhibitor shares the same absolute configuration as C(2,3,4,5) of alpha-L-fucopyranosides Bos taurus

Organism

Organism UniProt Comment Textmining
Bos taurus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
kidney
-
Bos taurus
-

Ki Value [mM]

Ki Value [mM] Ki Value maximum [mM] Inhibitor Comment Organism Structure
0.00004
-
(2S,3S,4R,5S)-2-[(biphenyl-4-ylamino)methyl]-5-methylpyrrolidine-3,4-diol
-
Bos taurus
0.00008
-
(2S,3S,4R,5S)-2-(1H-benzimidazol-2-yl)-5-methylpyrrolidine-3,4-diol
-
Bos taurus
0.000237
-
(2S,3R,4S,5S)-2-methyl-5-(phenylamino)pyrrolidine-3,4-diol
-
Bos taurus